Indrayani Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | 5.88 | 7.76 | 7.58 |
| Operating Expense | 4.54 | 5.97 | 5.94 |
| Net Profit | 0.08 | 0.47 | 0.13 |
| Net Profit Margin | 1.36 | 6.06 | 1.72 |
| Earning Per Share | 0.01 | 0.10 | 0.03 |
| EBIDTA | 1.34 | 1.79 | 1.64 |
| Effective Tax Rate | 2.24 | 8.99 | 2.44 |
| Particulars | Dec 2025 |
|---|---|
| Revenue | 5.88 |
| Operating Expense | 4.54 |
| Net Profit | 0.08 |
| Net Profit Margin | 1.36 |
| Earning Per Share | 0.01 |
| EBIDTA | 1.34 |
| Effective Tax Rate | 2.24 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 37.77 | 62.32 | 74.48 |
| Operating Expenses Annual | 32.29 | 56.66 | 65.83 |
| Operating Profit Annual | 8.99 | 9.28 | 8.80 |
| Interest Annual | 7.32 | 4.83 | 2.78 |
| Depreciation | 1.02 | 1.45 | 0.93 |
| Net Profit Annual | 1.45 | 1.46 | 5.06 |
| Tax Annual | -0.80 | 1.55 | 0.02 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 37.77 |
| Operating Expenses Annual | 32.29 |
| Operating Profit Annual | 8.99 |
| Interest Annual | 7.32 |
| Depreciation | 1.02 |
| Net Profit Annual | 1.45 |
| Tax Annual | -0.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.26 | 0.62 | 1.45 |
| Cash Flow from Operations | 17.35 | 26.09 | 8.33 |
| Cash Flow from Investing | -1.34 | -7.26 | -14.09 |
| Cash Flow from Financing | -16.22 | -19.19 | 4.93 |
| Cash Flow at the End | 0.06 | 0.26 | 0.62 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.26 |
| Cash Flow from Operations | 17.35 |
| Cash Flow from Investing | -1.34 |
| Cash Flow from Financing | -16.22 |
| Cash Flow at the End | 0.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 24.01 | 15.12 | 11.90 |
| PBIT Margin (%) | 21.31 | 12.79 | 10.65 |
| PBT Margin (%) | 18.42 | 10.21 | 6.92 |
| Net PROFIT Margin (%) | 3.84 | 2.34 | 6.79 |
| Return On Networth / Equity (%) | 2.51 | 2.78 | 12.48 |
| Return On Networth /Employed (%) | 6.69 | 7.23 | 10.59 |
| Return On Assets (%) | 1.23 | 1.38 | 7.54 |
| Total Debt / Equity (X) | 1.14 | 1 | 0.79 |
| Asset Turnover Ratio (%) | 0.32 | 0.59 | 1.11 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 24.01 |
| PBIT Margin (%) | 21.31 |
| PBT Margin (%) | 18.42 |
| Net PROFIT Margin (%) | 3.84 |
| Return On Networth / Equity (%) | 2.51 |
| Return On Networth /Employed (%) | 6.69 |
| Return On Assets (%) | 1.23 |
| Total Debt / Equity (X) | 1.14 |
| Asset Turnover Ratio (%) | 0.32 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 16.66 | 21.66 | 23.81 |
| Total Current Assets Annual | 80.62 | 71.50 | 49.33 |
| Non Current Assets Annual | 50.05 | 54.50 | 50.97 |
| Total Shareholders Funds Annual | 55.33 | 54.52 | 51.15 |
| Total Assets Annual | 130.68 | 126.01 | 100.30 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 16.66 |
| Total Current Assets Annual | 80.62 |
| Non Current Assets Annual | 50.05 |
| Total Shareholders Funds Annual | 55.33 |
| Total Assets Annual | 130.68 |
EPS (INR)
Expected
0.01
Reported
0.01
Surprise
0.00%
Sep 2025
EPS beaten by 0.00%
Jun 2025
EPS beaten by 0.00%
Mar 2025
EPS beaten by -25.00%
